Coming off Ozempic without regaining the weight

Coming off Ozempic, Wegovy or Mounjaro without regaining the weight comes down to one thing the scale never shows you: how much muscle you kept on the way down. When people stop a GLP-1, weight tends to return, and the trials are blunt about how much. The reason is mechanical, not a matter of willpower. A meaningful share of GLP-1 weight loss is muscle unless you train, and muscle is the tissue that sets how much your body burns at rest. Lose it, and you finish the descent with a lower metabolic floor, so the same meals that once held you steady now sit slightly above what you spend, and the gap refills as fat. The muscle you build while the medication does its work is the part that holds the result after the drug is gone.

TL;DR

• Between 25 and 39 percent of the weight lost on a GLP-1 is lean mass, not fat, unless you resistance train.
• After stopping semaglutide, people regained about two-thirds of their lost weight within a year in the trial extension.
• Regain is mostly fat because lost muscle lowered the resting metabolic rate, so the body burns less than it used to.
• Two to three strength sessions a week plus enough protein is what keeps the muscle, and the muscle is what holds the result.
• Whether and when to stop a GLP-1 is a decision for your prescribing doctor, never a training plan.

In this article

• 1. Why the weight comes back what the regain trials actually measured.
• 2. Why regain is a muscle problem the metabolic floor, explained.
• 3. How much muscle you lose on a GLP-1 the 25 to 39 percent range.
• 4. The muscle you keep is your metabolic floor why it decides the outcome.
• 5. Start training before you stop, not after the window that matters.
• 6. The strength dose that holds the line two to three sessions a week.
• 7. Protein when appetite comes back the habit that flips.
• 8. Read composition, not the scale the at-home signals.
• 9. The off-ramp itself the weeks around stopping.
• 10. What stays your doctor's call where the clinic ends and training begins.

GLP-1 receptor agonists, the class that includes semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), are remarkably good at one thing: removing weight. In the STEP 1 trial of once-weekly semaglutide 2.4 mg, adults lost a mean of 14.9 percent of body weight over 68 weeks, against 2.4 percent on placebo. Those are real, clinically meaningful results, and nothing here is an argument against the medication. What the drug does not decide is the composition of that loss, or what happens to your body once you stop taking it.

That second part is where most of the worry sits, and rightly so. A GLP-1 is not always meant to be permanent. At some point, with your doctor, you may taper, pause or stop, and the question that decides what happens next is not how much weight you lost. It is how much muscle you carried out the other side. This piece reframes the regain problem as a muscle problem, because once you see it that way, the path through it becomes obvious and largely in your control.

A note on what this is and is not. This is educational content written by a doctor, not medical advice and not a substitute for your prescribing clinician. Whether to start, continue, dose or stop a GLP-1 is a clinical decision between you and your doctor. What follows is the training and nutrition half of the equation, the half a studio can legitimately coach, set out so you can keep the result you worked for. If you want to put a number on your own situation first, our free GLP-1 Muscle-Loss Calculator estimates how much of your projected loss could be lean mass.

1. Why the weight comes back

The honest starting point is that regain after stopping a GLP-1 is common and partly expected. The medication works by suppressing appetite, slowing how fast the stomach empties and acting on the brain's hunger pathways, so you eat less without fighting for it. Take that suppression away and a normal appetite returns. The trials show what tends to happen next, and they are worth knowing before you stop so a few kilos coming back does not read as personal failure.

In the STEP 1 trial extension, participants who had lost weight on semaglutide regained about 11.6 percentage points of that weight in the year after stopping, roughly two-thirds of what they had lost, and the cardiometabolic improvements drifted back towards baseline alongside it. The SURMOUNT-4 trial of tirzepatide made the same point from the opposite direction: people who continued the drug from week 36 to week 88 lost a further 5.5 percent, while those switched to placebo regained 14.0 percent, a swing of more than 19 percentage points between staying on and coming off.

Read those numbers carefully, because there is a trap in them. They describe people who came off the drug without a structured strength-and-protein plan running underneath. That is the default the studies captured, and it is exactly the default this article is built to change. You are not the average participant in a withdrawal trial if you carry a trained body and a deliberate protein habit out of your time on the medication. The regain figures are the baseline risk, not your fixed fate.

We see this distinction in the studio constantly. A member who treated their months on a GLP-1 as a window to build a strength base behaves nothing like the trial average when they taper. The appetite still returns, but the body it returns to is a different body, one that burns more at rest and holds its composition while the eating settles. The drug bought the window. What they built inside it is what kept the door from swinging back.

The takeaway from the regain data is not despair, it is direction. Regain is the price of stopping without a maintenance engine. Build the engine and the same act of stopping looks completely different. That engine is muscle, which is where the rest of this goes.

2. Why regain is a muscle problem

The reason weight returns so readily is mechanical, and it traces back to what left the body on the way down. If you lost muscle while losing weight, and on a GLP-1 a real share of the loss is muscle unless you train, then you reach your lower weight with a body that burns less at rest than it used to. Muscle is metabolically active tissue. Less of it means a lower resting metabolic rate, the calories your body spends simply existing, which is the largest slice of most people's daily energy use.

Play that forward. You finish the descent eating like your former, heavier self but with the resting engine of a smaller, less muscular person. The arithmetic quietly turns against you: meals that once held you steady now sit a little above what you spend, and the surplus, small but daily, accumulates as fat. This is why regain so often comes back softer and rounder than the body you started with, even at the same weight on the scale. The kilos return, but the composition is worse.

We will not put a precise number on how much of regained weight is fat versus muscle, because there is no clean trial that measured it, and inventing a figure is not something a doctor should do. What the physiology supports, and what we present as rationale rather than a cited statistic, is the direction of travel: weight that returns after stopping tends to return as fat, while the muscle you lost is far harder to rebuild than it was to shed. That asymmetry is the entire case for protecting muscle on the way down. Our muscle-loss explainer walks through the same mechanism in more depth.

There is a corollary that members find clarifying. If regain is largely a muscle-and-metabolism story, then the lever that controls it is not eating less forever, which is unsustainable and not the point of taking the medication in the first place. The lever is keeping the muscle that keeps the metabolic floor high. You are not trying to white-knuckle a permanent deficit. You are trying to defend the tissue that lets you eat normally without the weight creeping back.

That reframing changes what off-ramp success even looks like. It is not the lowest possible number on the scale at the moment you stop. It is the highest possible amount of muscle carried into the months that follow, because that is the variable that decides whether the result holds or erodes. Train for the muscle, and the weight largely takes care of itself.

3. How much muscle you lose on a GLP-1

Here is the figure that anchors everything. The 2024 Lancet Diabetes and Endocrinology review by Prado and colleagues, the source we cite across all our writing on this, puts fat-free mass at 25 to 39 percent of the total weight lost on GLP-1 receptor agonists over the 36 to 72 weeks of typical trials. In plain terms, between a quarter and two-fifths of the weight leaving on the scale is not fat. It is muscle and the lean tissue that supports it.

Two pieces of honesty belong next to that number, and we will not bury either. First, the authors are clear that this muscle loss is largely driven by the sheer magnitude of the weight loss, not by an independent toxic effect of the drug on muscle. The medication is not attacking your muscle; it is removing weight efficiently, and muscle goes with it unless something signals the body to keep it. Second, this is not pound-for-pound worse than aggressive dieting. Non-pharmacological calorie restriction produces fat-free mass losses in the 10 to 30 percent range; the GLP-1 figure sits at the upper end largely because the weight loss is larger and faster, not because the mechanism is uniquely harmful.

It also matters that fat-free mass includes water and the mass of organs, not just contractile muscle, so the headline figure is not a clean readout of pure muscle. The two landmark trials help calibrate. In the STEP 1 substudy, total fat mass fell 19.3 percent while total lean body mass fell 9.7 percent over 68 weeks, so fat fell faster than lean and the proportion of the body that was lean actually rose by about three points. That is the preferential fat loss the drug is designed to deliver. The point is not that the medication is bad for muscle. It is that a quarter to two-fifths of a large loss is still a lot of muscle to surrender if you do nothing to keep it.

This is precisely why we built our reasoning, and our coaching, around the line that runs through the whole studio: the drug decides how much weight you lose, you decide how much of it is muscle. A member starting a GLP-1 who also starts training is choosing to land that 25 to 39 percent figure at its floor rather than its ceiling. The medication does its half well. The muscle-keeping half is the half it does not do, and the half that decides the off-ramp.

If you want to see roughly where you would sit, the free GLP-1 Muscle-Loss Calculator applies this evidence to your own starting weight and projected loss, so the abstract range becomes a number you can act on rather than worry about.

4. The muscle you keep is your metabolic floor

Muscle is not a cosmetic concern, and after 40 it is the single tissue most tied to staying capable through the decades ahead. From around 40, adults lose muscle steadily, on the order of 8 percent per decade, and the loss accelerates later in life. That slow erosion is sarcopenia, and a fast, muscle-costly weight loss layered on top of it can run the muscle account down quickly. The clinical definitions make the stakes concrete: low muscle mass together with low strength or performance, with grip-strength thresholds under 28 kg for men and under 18 kg for women among the markers of trouble.

Connect that to the off-ramp and the logic closes. Resting metabolic rate is largely a function of how much lean tissue you carry. Defend the muscle and you defend the floor, the baseline calorie burn that decides whether returning appetite gets absorbed as recovery and load or deposited as fat. Erode the muscle and you lower the floor, which is the quiet engine of regain. The muscle you keep is not just about strength or how you look. It is the metabolic setting your body returns to once the drug stops holding your appetite down.

This is the longevity argument as much as the weight argument, and the two are the same argument. The strength that protects your weight after a GLP-1 is the same strength that lets you rise from a chair, carry shopping up stairs and catch a stumble in your sixties and beyond. You are not training to win the twelve weeks on the medication. You are training so that what you can still do decades from now is not quietly negotiated away during a rapid weight loss you thought was purely about fat.

In the studio, this is the conversation that reframes the whole project for members in their forties and fifties. They arrive thinking about the number on the scale and the dress or suit size. They leave thinking about grip strength, the ease of standing from the floor, and how much they can still carry, because those are the markers that track the metabolic floor and the independent decades both. The weight result becomes a byproduct of training for capability, which is a far more durable thing to chase than a number.

There is a practical edge to this too. Because the floor is what matters, the off-ramp is not a sprint to the lowest weight followed by a relaxation. It is the moment you most need the muscle intact, which means the training does not pause when the medication does. The members who hold their results treat coming off the drug as the point where the strength work matters most, not least.

5. Start training before you stop, not after

The most common and most costly off-ramp mistake is to think of training as something you start once the drug stops. By then a meaningful share of the descent, and a meaningful share of the muscle loss, has already happened. The muscle you want to carry into the off-ramp has to be built or defended while you are still on the medication, in the window the appetite suppression hands you. Starting strength training the day you stop is starting a chapter late.

There is an unexpected advantage to training during the on-drug phase. The appetite suppression that makes protein hard to eat also makes recovery management simpler in one respect: you are not fighting hunger-driven overeating, so the calories you do take in can be steered deliberately toward protein and training fuel. The window the drug opens is the easiest time you will ever have to add a strength habit, precisely because the eating is under control. Waste it and you spend the off-ramp trying to rebuild muscle while appetite is climbing, which is the hardest possible time to do it.

The evidence that loading muscle during weight loss preserves it is clear, even though it predates the GLP-1 era. In a 2017 New England Journal of Medicine trial of older adults losing about 9 percent of body weight, lean mass fell 5 percent with aerobic exercise alone, 2 percent with resistance training, and 3 percent with both combined, and the groups that lifted preserved physical function best. That study used diet-induced weight loss rather than a drug, so it establishes the mechanism rather than a GLP-1-specific result, but the mechanism is exactly the one that matters here: load the muscle and the body holds on to far more of it.

We see the timing effect play out in who holds their result and who does not. A member who began strength work in month two of their medication, while the appetite was still suppressed, walks into the taper with a base to defend. A member who waited until they had stopped, and only then thought about training, is trying to build under the worst conditions, with hunger rising and motivation often dipping. Same person, same drug, completely different off-ramp, decided almost entirely by when the training started.

If you are still early on a GLP-1, the instruction is simple: start now, not at the end. The bonus is that the strength base you build in the easy window is the same base that defends you in the hard one, so none of the work is wasted. You are not training twice. You are training once, early, for a result you will collect later.

6. The strength dose that holds the line

Muscle is kept by the demand you place on it, which means the prescription is reassuringly modest. Two to three resistance sessions a week, built from compound patterns, squat, hinge, push, pull and loaded carry, and progressed when you own the top of the rep range with clean form, is enough to maintain what you built. This is not a punishing volume of training. It is the minimum effective dose, and the point is consistency over intensity, because the body holds tissue it is regularly asked to use and sheds tissue it is not.

The single most important instruction for the off-ramp is the least surprising one: do not stop lifting when you stop the drug. Take the demand away and the body has no reason to keep muscle it is no longer being asked to use, which is exactly when erosion sets in. The cadence that built the muscle is the cadence that defends it. If anything, the weeks after stopping are the time to be most consistent, because that is when the appetite is rising and the muscle-keeping signal matters most.

Form earned before load is added is not a slogan, it is a safety requirement, especially relevant during rapid weight loss when bone can be losing density too. Mechanically loading bone through progressive weight-bearing strength training is the stimulus bone adapts to, where aerobic exercise alone does little. The two words that make heavier loading appropriate during weight loss are gradual and well-executed, which is why a coached eye on the movement pattern is worth more during a GLP-1 phase than at almost any other time. Our bone-density piece covers that argument in full.

What this looks like in practice at Catalyst is unglamorous and effective. A member coming off their medication runs the same two-to-three-session week they ran on it: a handful of compound lifts, loaded conservatively, progressed a little each week, with the bar moving and the form holding. No heroics, no chasing fatigue. The aim is not to be sore. The aim is to keep giving the muscle a reason to stay, week after week, while the rest of the body adjusts to life without the drug.

The bonus insight here is about what consistency buys you metabolically. Keeping the bar moving keeps the resting metabolic rate the muscle supports, which is the quiet difference between weight that holds and weight that creeps. You are not lifting to burn calories in the session, which is a small effect. You are lifting to keep the floor high all day, every day, which is the large one. That is why two to three sessions a week beats an occasional heroic effort: the floor is held by what you do regularly, not by what you do once.

7. Protein when appetite comes back

On a GLP-1, the hard part of protein is eating enough against a suppressed appetite. Coming off, the challenge flips entirely. Hunger returns, food becomes easy again, and the new risk is that total intake climbs faster than protein does, so the extra calories arrive as everything except the macronutrient that protects muscle. The defence is a habit, not a diet: eat protein first at each meal, keep it deliberate, and hold a steady floor rather than letting intake drift back to whatever appetite dictates.

The evidence on how much is consistent. Protein intakes around 1.6 g per kg of body weight per day maximise the lean-mass gains from resistance training, with benefit up to about 2.2 g/kg, and the building-and-maintaining range sits at roughly 1.4 to 2.0 g/kg. In a calorie deficit the best-supported targets run higher still. The practical instruction we give is a floor of 1.2 to 1.6 g/kg that most people can actually reach, and a target of 1.6 to 2.2 g/kg for those training hard and tolerating the food. That floor does not relax because appetite came back. If anything, it is your anchor while everything else loosens.

Expect appetite to return, and plan for it rather than be ambushed by it. A returning appetite is not a relapse, it is your normal physiology coming back online without the medication damping it. The people who hold their composition are the ones who saw it coming, kept protein structured, and let the training absorb the extra fuel as recovery and load rather than as fat. One important medical caveat: if you have any kidney concern, confirm your specific protein target with your doctor or dietitian before holding a high intake through the off-ramp.

A member of ours described the off-ramp protein habit as the thing that made the difference, not because it was complex but because it was automatic. By the time they stopped the drug, eating protein first at every meal was a default they no longer thought about, so when hunger came roaring back the protein was already locked in and the only variable left to manage was the rest of the plate. The habit, drilled during the easy window, did the work during the hard one.

The bonus here is that protein does double duty on the off-ramp. It is the raw material the training uses to keep muscle, and it is the most satiating of the three macronutrients, so a structured protein floor also blunts some of the returning hunger directly. You are not just protecting muscle, you are making the appetite easier to live with at the same time. That is why protein, not calorie counting, is the lever we put first when a member comes off their medication.

8. Read composition, not the scale

The scale is the wrong instrument for judging an off-ramp, because it cannot tell muscle from fat, and the whole game is composition. A few kilos returning in the first months off is common in the trial data and is not, by itself, evidence the muscle is going. Judge the body by what it can do and how it is shaped, not only by what it weighs, or you will react to the wrong signal at the wrong time.

You do not need a studio body-composition scan to read this at home. Take a self-baseline at the point you stop the drug, weight, waist measurement against your height, and a simple strength self-test such as the load you can comfortably manage on a key lift. Re-check a few weeks later. The signal that matters is the relationship between them. Strength holding or rising while weight ticks up modestly is the at-home evidence that what is returning is not the muscle you fought to keep. Waist creeping while strength holds tells you to tighten the protein and the consistency, not to panic.

This matters because the scale, read alone, drives bad decisions on the off-ramp. A member who sees the number rise and concludes the plan has failed might cut food hard and drop training out of frustration, which is precisely the move that accelerates muscle loss and makes the next regain worse. Reading composition instead keeps them on the actual task, which is defending muscle, and stops the scale from triggering a spiral that the body did not warrant.

We coach members to track two lines, not one: the scale and a strength marker. When both are visible side by side, the story is almost always reassuring, because the strength line tells you the muscle is holding even on the weeks the scale wobbles. Over a few months the strength line is the one that predicts whether the result lasts, and it is the one most people never think to watch. The free GLP-1 Muscle-Loss Calculator gives you a starting estimate to baseline against.

The bonus insight is that this same habit, reading composition over weight, is what separates people who keep results for years from people who cycle. It outlasts the off-ramp entirely. Once you have learned to trust the strength marker over the scale, you have the literacy to maintain a body composition for life, drug or no drug, which is the real deliverable hiding inside the off-ramp question.

9. The off-ramp itself

It helps to map the weeks around stopping so you know what usually shifts and what your job is in each phase. This is a general orientation, not a medical timeline, individual experiences vary widely, and your doctor sets the dosing schedule. In the final weeks on the drug, appetite is still suppressed and training tends to go well, so the job is to bank the strength: keep two to three sessions a week and hold the protein floor while it is easy. This is the cheapest muscle you will ever build, so build it.

Through the taper or the stop, appetite starts to return, sometimes sharply within a few weeks. The job here is to hold the sessions and not let training slide just because eating is getting easier again. This is the danger window, the gap between appetite waking up and training slipping, and it is where most regain is quietly decided. Keep the lifts in the diary first; the eating is far easier to steer when the loading stays put. In the first months off, hunger climbs back towards its old level and energy is often higher, so keep protein deliberate, keep adding load on the lifts, and watch the strength markers rather than only the scale.

In the long run, you arrive at a new normal without the drug holding the appetite down, and the framing shifts one last time. Training and protein stop being a phase and become the maintenance. This is the steady state, not a project with an end date. The members who hold their composition are not the ones who found a clever trick for the off-ramp, they are the ones who accepted that the strength work was always going to be permanent, and the medication was the temporary part.

The most important sentence in this whole section is the one members resist hardest: the twelve weeks were the foundation, not the event. The time on the medication was never the main act with the drug as the star. It was the build of a strength base designed to outlast the drug, which is why the off-ramp is the chapter the whole thing was pointing at. A prescription gets you part of the way down. The training is the part that stays once the prescription stops.

If you would rather not run the off-ramp alone, this is the natural moment to have it coached. The same principles drive our online coaching for readers anywhere in the world, and we built a self-guided GLP-1 Muscle Protocol around exactly this brief: a twelve-week strength programme, a protein system for a switched-off appetite, an at-home muscle-monitoring kit, and an off-ramp plan, with the evidence referenced so a sceptical doctor would nod. Self-guided or coached, the instruction is the same: lose the fat, keep the structure.

10. What stays your doctor's call

One line governs everything in this article, and it is worth stating without softening. Whether to stop a GLP-1, when to stop, and whether to taper or step down the dose are clinical decisions for you and your prescribing doctor. Nothing here is advice to start, stop or change a medication. Catalyst is not a medical provider and does not prescribe. If you are thinking about coming off, that conversation belongs in the clinic, not in a training plan, and certainly not in a blog post.

What is squarely yours, and a studio's, to coach is what the training and the eating do in the weeks around that decision, whatever schedule your doctor sets. The drug schedule is the doctor's domain. The strength base, the protein floor and the habit of showing up are the training domain, and they do not change because the medication is tapering. Keeping these two lanes clear is not a legal formality, it is what makes the advice trustworthy: we will tell you exactly how to defend your muscle, and we will not pretend to know things about your medication that only your doctor does.

There is a specific medical handoff worth naming. If you have a kidney condition, a high-protein floor is the one piece of this plan to clear with your doctor or dietitian first. If you are at increased fracture risk or have low bone density, the progressive-loading argument is sound but the execution must be gradual and supervised, which is another reason form earned before load is not optional. These are exactly the cases where a doctor co-founder in the building, and a coached eye on the movement, change the risk profile of the work.

The reason this division of labour matters for your result, and not just your safety, is that it keeps you focused on the variable you can actually move. You cannot out-train a dosing decision, and you should not try. What you can do is arrive at whatever decision your doctor makes with the maximum amount of muscle and the strongest possible metabolic floor, so that the off-ramp starts from the best position available to you. That is the whole job, and it is entirely in your hands.

How to pick what to do first

If you are reading this while still on a GLP-1, the priority order is unambiguous: start strength training now, before you stop, while the appetite suppression makes the eating easy and the muscle is cheapest to build. Two to three sessions a week, compound patterns, conservative loading, is the whole prescription. Pair it with a protein floor of 1.2 to 1.6 g per kg per day, eaten protein-first, drilled into a habit that will hold when appetite returns. Everything else is detail layered on top of those two non-negotiables.

If you are already at or past the point of stopping, the order is the same but the urgency is higher. Do not wait to feel motivated; put the two or three sessions in the diary first and let the eating follow, because the danger window is precisely the gap between rising appetite and slipping training. Take an at-home composition baseline today, weight, waist-to-height, and a strength self-test, so you are reading the right signal from the start. A few kilos on the scale with strength holding is a body behaving well, not a plan failing.

Before any of this, the diagnostic worth running is an honest read of where your muscle, strength and capacity actually sit, because that decides how aggressively to load and where the weak points are. That is what our 4-Pillar Healthspan Assessment measures across body composition, cardiorespiratory fitness, stability and strength, and it is the cleanest way to turn a general plan into your plan. The free GLP-1 Muscle-Loss Calculator is the lighter first step if you just want to see the muscle-loss range for your own numbers.

Frequently asked questions

Q. Will I regain the weight after stopping Ozempic?

Some regain is common in the trial data, with people regaining roughly two-thirds of their lost weight in the year after stopping semaglutide without a structured plan underneath. But the regain studies measured people who came off the drug with no strength training or protein strategy running. If you carry muscle and a deliberate protein habit out of your time on the medication, you are not the average participant in those trials, because the muscle keeps your metabolic floor high and the floor is what decides whether the weight holds.

Q. How do I keep the weight off after coming off a GLP-1?

Keep the muscle. Two to three resistance sessions a week, built from compound lifts and progressed gradually, plus a protein floor of about 1.2 to 1.6 g per kg of body weight per day, is what defends the muscle that defends your metabolic rate. Read composition rather than the scale, expect appetite to return and plan for it, and treat the training as permanent maintenance rather than a phase that ends with the prescription. Whether and when to stop the drug, though, is always your doctor's decision.

Q. Does Ozempic make you lose muscle?

A meaningful share of GLP-1 weight loss is lean mass: between 25 and 39 percent of the total weight lost, according to a 2024 Lancet Diabetes and Endocrinology review. Importantly, this is largely driven by the size and speed of the weight loss rather than a direct toxic effect of the drug on muscle, and it is not pound-for-pound worse than aggressive dieting. The fix is the same regardless of the cause: resistance training and enough protein signal the body to keep the muscle it would otherwise shed.

Q. Is the regain after stopping mostly fat or muscle?

There is no clean trial that has measured the exact fat-versus-muscle split of regained weight, so we will not put a number on it. The physiology points clearly in one direction, which we present as rationale rather than a cited statistic: weight that returns tends to come back as fat, because lost muscle lowered the resting metabolic rate, while the muscle itself is far harder to rebuild than it was to lose. That asymmetry is exactly why protecting muscle on the way down, and continuing to train after stopping, is the whole strategy.

Q. When should I start strength training if I am on a GLP-1?

Now, before you stop, not after. The appetite suppression while you are on the drug is the easiest window you will ever have to build a strength habit, because the eating is already under control. Starting the day you stop means trying to build muscle under the hardest conditions, with hunger rising. The strength base you build early is the same base that defends you during the off-ramp, so none of the early work is wasted.

Coming off a GLP-1 without regaining the weight is not a willpower problem and it is not luck. It is a muscle problem with a known solution. The drug removes weight efficiently while you take it, but it does nothing once it is out of your system, and a quarter to two-fifths of that loss is muscle unless you train. The muscle you build and defend is what keeps your metabolic floor high, and the floor is what holds the result when appetite returns. Build it early, keep it deliberately, and read composition rather than the scale. For more on the mechanism, see our pieces on GLP-1 muscle loss and coming off without regaining fat.

If you want this coached rather than self-guided, our online coaching runs the same programme for readers anywhere in the world, and the self-guided GLP-1 Muscle Protocol packages the twelve-week plan, the protein system, the at-home monitoring kit and the off-ramp plan into one product. Start by estimating your own muscle-loss range with the free GLP-1 Muscle-Loss Calculator, then book a complimentary 30-min consultation through our appointments page when you want a coached read on where to load first.

Citations

Prado CM, Phillips SM, Gonzalez MC, Heymsfield SB. Muscle matters: the effects of medically induced weight loss on skeletal muscle. Lancet Diabetes Endocrinol. 2024;12(11):785-787.

Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002.

Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553-1564.

Aronne LJ, Sattar N, Horn DB, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (SURMOUNT-4). JAMA. 2024;331(1):38-48.

Villareal DT, Aguirre L, Gurney AB, et al. Aerobic or Resistance Exercise, or Both, in Dieting Obese Older Adults. N Engl J Med. 2017;376(20):1943-1955.

Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020;21(3):300-307.